Skip to main content
. 2005 Jan 11;92(2):312–319. doi: 10.1038/sj.bjc.6602262

Table 4. Frequency of intraclonal sequence heterogeneity before and after treatment for H. pylori.

  Before treatment
After treatment
Case Tumour-derived sequences/clones sequenced Frequency of sequence heterogeneity (%) Tumour-derived sequences/clones sequenced Frequency of sequence heterogeneity (%)
1a 5/11 0.37
1b 5/11 0.00
2 2/11 0.25
3 8/9 0.30 4/6 0.12
4 6/6 0.49 6/6 0.10
5 ND ND 10/10 0.18

ND=not determined.